跳至主要内容
临床试验/NCT00002848
NCT00002848已完成不适用

SUPPORTIVE-EXPRESSIVE GROUP THERAPY FOR MEN WITH PRIMARY PROSTATE CANCER

Gary Morrow14 个研究点 分布在 1 个国家目标入组 480 人开始时间: 1997年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Gary Morrow
入组人数
480
试验地点
14

研究概览

简要总结

RATIONALE: Developing coping strategies may help improve the quality of life of patients with prostate cancer.

PURPOSE: This randomized clinical trial is comparing the effect of group therapy with written educational materials on the quality of life of men with stage I or stage II prostate cancer.

详细描述

OBJECTIVES:

  • Determine the feasibility of providing group support, and evaluate the effect of supportive-expressive group therapy vs. written educational material on the psychological health and quality of life of men with stage I/II prostate cancer.

OUTLINE: Patients are stratified by prior hormonal therapy.

Patients continue standard oncologic treatment concurrently with supportive-expressive group therapy.

Supportive-expressive group therapy consists of twelve 90-minute weekly meetings with 8-12 members and 2 cotherapists and is based on the following themes: building bonds, expressing emotions, detoxifying dying, taking time to prioritize and set realistic goals, fortifying families, and dealing with doctors. Each session commences with a brief stress reduction exercise and ends with a brief cognitive restructuring imagery exercise. The main portion of the meeting emphasizes providing an environment in which patients can share their concerns, feelings, and thoughts openly and honestly. The role of the cotherapist is to facilitate expression of patients' concerns, offer empathy, and continue to encourage patients to express their feelings and thoughts.

研究设计

研究类型
Interventional

入排标准

性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Gary Morrow
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Gary Morrow

Director, URCC CCOP Research Base

University of Rochester

研究点 (14)

Loading locations...

相似试验